Montis Financial LLC Invests $215,000 in Colgate-Palmolive (NYSE:CL)

Montis Financial LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 2,364 shares of the company’s stock, valued at approximately $215,000.

Several other hedge funds have also added to or reduced their stakes in CL. State Street Corp grew its position in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after buying an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA grew its position in Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock worth $988,997,000 after buying an additional 557,492 shares in the last quarter. Amundi increased its stake in Colgate-Palmolive by 12.8% during the 4th quarter. Amundi now owns 9,200,144 shares of the company’s stock worth $806,015,000 after acquiring an additional 1,040,604 shares during the period. Finally, Barclays PLC raised its holdings in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE CL opened at $89.80 on Friday. The company has a market capitalization of $72.87 billion, a price-to-earnings ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock has a fifty day simple moving average of $89.02 and a 200 day simple moving average of $94.82.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business earned $0.87 earnings per share. Sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Analysts Set New Price Targets

CL has been the topic of a number of recent analyst reports. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Barclays dropped their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a research note on Friday. Piper Sandler cut their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Raymond James reiterated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.